Thyroid Cancer

With a deadline of April 14, the FDA will soon make its final approval decision on lenvatinib as a treatment for patients with progressive, radioactive iodine (RAI)-refractory differentiated thyroid cancer (DTC).

The Food and Drug Administration's calendar for making decisions on new cancer drugs and indications is taking shape for 2015, and the clock is ticking on at least 13 applications for novel agents and new therapeutic settings for existing drugs.

The latest in cancer prevention, diagnosis & treatment.

Researchers urge restraint when it comes to treating thyroid cancer in children.

Types of thyroid cancer.

Patients may be asked to take steps to deplete their body's natural store of iodine so the thyroid will more readily absorb the radioactive iodine treatment and maximize treatment effectiveness

Thyroid cancer's high survival rate masks the sometimes tricky tumor.

KRAS gene mutations are detected in various cancers, including colorectal.

Updates from the 2007 meeting of the American Society of Clinical Oncology includes news on liver, kidney, lung, colon, pancreatic and breast cancers.